How Syndromic Molecular Diagnostics is Replacing Traditional Panel-Based Ordering of Infectious Disease Tests

Ads

You May Also Like

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional ...